Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated Stimulation demonstrating selectivity towards cytokine production

International Immunopharmacology

Volumn 11, Issue 8, 2011, Pages 1002-1011

  Xia, Yu Xiu C ^a   Sun, Shan Shan ^b   Kuek, Li Eon ^a   Lopata, Andreas L ^b,c   Hulett, Mark D ^d   MacKay, Graham A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b RMIT UNIVERSITY   (Australia)

^c JAMES COOK UNIVERSITY   (Australia)

^d LA TROBE UNIVERSITY   (Australia)

Author keywords

Adenosine; Cytokines; Fc RI; IgE; MAPK; Mast cells

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); CALCIUM; FC EPSILON RI; FC RECEPTOR; IMMUNOGLOBULIN E; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; UNCLASSIFIED DRUG;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN MAST CELL LINE 1; IMMUNOSTIMULATION; MAST CELL; MAST CELL DEGRANULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 84860422939     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.02.017     Document Type: Article

References (47)

1. Kalesnikoff J, Galli SJ. New developments in mast cell biology. Nat Immunol 2008;9:1215-23.
2. Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 2007;7:93-104. (Pubitemid 46174857)
3. Sellge G, Bischoff SC. Isolation, culture, and characterization of intestinal mast cells. Methods Mol Biol 2006;315:123-38.
4. Saito H. Culture of human mast cells from hemopoietic progenitors. Methods Mol Biol 2006;315:113-22.
5. Kirshenbaum AS, Metcalfe DD. Growth of human mast cells from bone marrow and peripheral blood-derived CD34+ pluripotent progenitor cells. Methods Mol Biol 2006;315:105-12.
6. Butterfield JH, Weiler D, Dewald G, Gleich GJ. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 1988;12:345-55.
7. Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, Beaven MA, et al. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FceRI or FcγRI. Leuk Res 2003;27:677-82. (Pubitemid 36683255)
8. Nilsson G, Blom T, Kusche-Gullberg M, Kjellen L, Butterfield JH, Sundstrom C, et al. Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol 1994;39:489-98. (Pubitemid 24227772)
9. Xia H, Kepley C, Sakai K, Chelliah J, Irani A, Schwartz L. Quantitation of tryptase, chymase, FceRIα, and FceRIγ mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J Immunol 1995;154: 5472-80.
10. Kraft S, Kinet J-P. New developments in FceRI regulation, function and inhibition. Nat Rev Immunol 2007;7:365-78. (Pubitemid 46674486)
11. McDonnell JM, Beavil AJ, Mackay GA, Jameson BA, Korngold R, Gould HJ, et al. Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor. Nat Struct Biol 1996;3:419-26. (Pubitemid 26139440)
12. Wedi B, Lewrick H, Butterfield JH, Kapp A. Human HMC-1 mast cells exclusively express the FcγRII subtype of IgG receptor. Arch Dermatol Res 1996;289:21-7. (Pubitemid 27011063)
13. Rigby LJ, Trist H, Snider J, Hulett MD, Hogarth PM, Epa VC. Monoclonal antibodies and synthetic peptides define the active site of FceRI and a potential receptor antagonist. Allergy 2000;55:609-19. (Pubitemid 30438993)
14. Kepley CL, Youssef L, Andrews RP, Wilson BS, Oliver JM. Syk deficiency in nonreleaser basophils. J Allergy Clin Immunol 1999;104:279-84. (Pubitemid 29420421)
15. Feoktistov I, Goldstein AE, Biaggioni I. Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells. Mol Pharmacol 1999;55:726-34. (Pubitemid 29165438)
16. Okayama Y, Kagaya S, Yuki K, Arai T, Saito H. Roles of the transmembrane domain and the cytoplasmic domain of FceRIα in immunoglobulin E-mediated upregulation of surface FceRI expression. Clin Expert Allergy 2007;37:451-8. (Pubitemid 46393235)
17. Borkowski TA, Jouvin M-H, Lin S-Y, Kinet J-P. Minimal requirements for IgEmediated regulation of surface FceRI. J Immunol 2001;167:1290-6. (Pubitemid 32703124)
18. Metcalfe DD. Mast cells and mastocytosis. Blood 2008;112:946-56.
19. de Boer OJ, van der Meer JJ, Teeling P, van der Loos CM, Idu MM, van Maldegem F, et al. Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. J Pathol 2010;220:499-508.
20. Hueber AJ, Asquith DL, Miller AM, Reilly J, Kerr S, Leipe J, et al. Mast cells express IL-17A in rheumatoid arthritis synovium. J Immunol 2010;184:3336-40.
21. Ackermann L, Harvima IT, Pelkonen J, Ritamaki-Salo V, Naukkarinen A, Harvima RJ, et al. Mast cells in psoriatic skin are strongly positive for interferon-gamma. Br J Dermatol 1999;140:624-33. (Pubitemid 29191379)
22. Möller A, Henz BM, Grützkau A, Lippert U, Aragane Y, Schwarz T, et al. Comparative cytokine gene expression: regulation and release by human mast cells. Immunology 1998;93:289-95. (Pubitemid 28088299)
23. Zhao W, Oskeritzian CA, Pozez AL, Schwartz LB. Cytokine production by skinderived mast cells: endogenous proteases are responsible for degradation of cytokines. J Immunol 2005;175:2635-42. (Pubitemid 41113878)
24. Grützkau A, Kruger-Krasagakes S, Kogel H, Möller A, Lippert U, Henz BM. Detection of Intracellular interleukin-8 in human mast cells: flow cytometry as a guide for immunoelectron microscopy. J Histochem Cytochem 1997;45:935-46.
25. Wu L, Feng B-S, He S-H, Zheng P-Y, Croitoru K, Yang P-C. Bacterial peptidoglycan breaks down intestinal tolerance via mast cell activation: the role of TLR2 and NOD2. Immunol Cell Biol 2007;85:538-45. (Pubitemid 47530587)
26. Wierecky J, Grabbe J, Wolff HH, Gibbs BF. Cytokine release from a human mast cell line (HMC-1) in response to stimulation with anti-IgE and other secretagogues. Inflamm Res 2000;49:7-8.
27. Weber S, Babina M, Krüger-Krasagakes S, Grützkau A, Henz B. A subclone (5 C6) of the human mast cell line HMC-1 represents a more differentiated phenotype than the original cell line. Arch Dermatol Res 1996;288:778-82. (Pubitemid 26388138)
28. Puri N, Roche PA. Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms. Proc Nat Acad Sci U S A 2008;105:2580-5. (Pubitemid 351520556)
29. Vig M, Kinet J-P. Calcium signaling in immune cells. Nat Immunol 2009;10:21-7.
30. Costello PS, Turner M, Walters AE, Cunningham CN, Bauer PH, Downward J, et al. Critical role for the tyrosine kinase Syk in signaling through the high affinity IgE receptor of mast cells. Oncogene 1996;13:2595-605. (Pubitemid 27046115)
31. Youssef LA, Wilson BS, Oliver JM. Proteasome-dependent regulation of Syk tyrosine kinase levels in human basophils. J Allergy Clin Immunol 2002;110:366-73.
32. Kraft S, Rana S, Jouvin MH, Kinet JP. The role of the FceRI β-chain in allergic diseases. Int Arch Allergy Immunol 2004;135:62-72. (Pubitemid 39279433)
33. Lin S, Cicala C, Scharenberg AM, Kinet J-P. The FceRIβ subunit functions as an amplifier of FceRIγ-mediated cell activation signals. Cell 1996;85:985-95. (Pubitemid 26231166)
34. Akizawa Y, Nishiyama C, Hasegawa M, Maeda K, Nakahata T, Okumura K, et al. Regulation of human FceRIβ chain gene expression by Oct-1. Int Immunol 2003;15:549-56. (Pubitemid 36519393)
35. Cruse G, Kaur D, Leyland M, Bradding P. A novel FceRIβ-chain truncation regulates human mast cell proliferation and survival. FASEB J 2010;24:4047-57.
36. Takahashi K, Hayashi N, Kaminogawa S, Ra C. Molecular mechanisms for transcriptional regulation of human high-affinity IgE receptor β-chain gene induced by GM-CSF. J Immunol 2006;177:4605-11. (Pubitemid 44469792)
37. Gonzalez-Espinosa C, Odom S, Olivera A, Hobson JP, Martinez MEC, Oliveira-dos- Santos A, et al. Preferential signaling and induction of allergy-promoting lymphokines uponweak stimulation of the high affinity IgE receptor onmast cells. J ExpMed 2003;197:1453-65. (Pubitemid 36682544)
38. Alvarez-Errico D, Lessmann E, Rivera J. Adapters in the organization of mast cell signaling. Immunol Rev 2009;232:195-217.
39. Feoktistov I, Biaggioni I. Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 1995;96:1979-86.
40. Wong CK, Tsang CM, Ip WK, Lam CWK. Molecular mechanisms for the release of chemokines from human leukemic mast cell line (HMC)-1 cells activated by SCF and TNF-α: roles of ERK, p38 MAPK, and NF-κB. Allergy 2006;61:289-97.
41. Gilfillan AM, Rivera J. The tyrosine kinase network regulating mast cell activation. Immunol Rev 2009;228:149-69.
42. Haskó G, Csóka B, Németh ZH, Vizi ES, Pacher P. A2B adenosine receptors in immunity and inflammation. Trends Immunol 2009;30:263-70.
43. McGarrigle D, Huang X-Y. GPCRs signaling directly through src-family kinases. Sci STKE 2007:pe35.
44. Lee SA, Fitzgerald SM, Huang SK, Li C, Chi DS, Milhorn DM, et al. Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1β. Am J Respir Cell Mol Biol 2004;31: 283-91. (Pubitemid 39180297)
45. Hundley TR, Gilfillan AM, Tkaczyk C, Andrade MV, Metcalfe DD, Beaven MA. Kit and FceRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 2004;104:2410-7. (Pubitemid 39331841)
46. Baghestanian M, Hofbauer R, Kiener HP, Bankl HC, Wimazal F, Willheim M, et al. The c-kit ligand stem cell factor and anti-IgE promote expression of monocyte chemoattractant protein-1 in human lung mast cells. Blood 1997;90:4438-49. (Pubitemid 27508449)
47. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mastcell infiltration of airway smooth muscle in asthma. N Engl J Med 2002;346: 1699-705. (Pubitemid 34547483)